Particle.news

Download on the App Store

Study Identifies Midkine as Blocker of Alzheimer’s Amyloid‑β Assembly

Biophysical assays pinpoint inhibition of specific amyloid‑β growth steps.

Image

Overview

  • Researchers from St. Jude Children’s Research Hospital and Van Andel Institute report the findings in Nature Structural & Molecular Biology on August 21, 2025.
  • Midkine prevents amyloid‑β from sticking together by inhibiting elongation and secondary nucleation during assembly formation.
  • Thioflavin T fluorescence assays, circular dichroism, electron microscopy and nuclear magnetic resonance support a direct interaction between midkine and amyloid‑β.
  • Alzheimer’s model mice lacking the midkine gene show increased amyloid‑β assemblies, indicating a protective role in vivo.
  • The work is preclinical, and the team plans to map the binding interface to guide small‑molecule designs that could mimic midkine’s effect.